-
It seems reasonable to assume that atorva-statin has some anti-ischemic properties, based on the strong correlation between subjective angina reduction and reduction in objective ischemia demonstrated on AECG monitoring. However, there was no incremental benefit to the combination of atorvastatin and amlodipine.
-
Clinicians should consider prescribing levothyroxine at bedtime since this study demonstrates significantly improved thyroid hormone levels compared to morning intake.
-
Rivaroxaban may be dabigatran's first competitor; a new way to measure non-adherence to medication therapy; FDA Actions.
-
Immunochemical fecal occult blood testing (i-FOBT) is becoming increasingly popular as a screening tool for colorectal cancer (CRC).
-
Easily obtained clinical variables can identify patients at very low risk for subarachnoid hemorrhage.
-
The ECG shown above was obtained from an older man with palpitations. He was hemodynamically stable with a systolic BP of 140 mm Hg at the time this tracing was recorded. How do you interpret the rhythm? What are your initial priorities?
-
A decision analysis shows that active surveillance is a good option for men age 65 and older with low-risk prostate cancer (Gleason score of 6 or less). Active surveillance results in the highest quality-of-life scores compared with different treatment options, and 61% of these men will go on to treatment after a median of 8.5 years, with a slight increased mortality risk. Only 10% of men currently receive active surveillance for low-risk prostate cancer
-
The most recent advice from the U.S. Department of Agriculture (2005) recommends that the general population of adults not consume > 2300 mg/day of sodium, and that persons with hypertension (HTN) consume ≤ 1500 mg/day.
-
The first oral contraceptive combined with a folate has been approved by the FDA.
-
A stroke "weekend effect" on mortality has been noted in studies reported from countries other than the United States.